PS101. Oral Ketamine for Treatment Resistant Major Depression – A double blind randomized controlled trial
Author(s) -
Yoav Domany,
Maya BleichCohen,
Nadav Stoppelman,
Talma Hendler,
Ricardo Tarrasch,
Shaul Schreiber,
Roi Meidan,
Haggai Sharon
Publication year - 2016
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyw043.101
Subject(s) - randomized controlled trial , double blind , treatment resistant depression , depression (economics) , ketamine , medicine , psychiatry , psychology , major depressive disorder , alternative medicine , placebo , mood , pathology , economics , macroeconomics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom